SCHEMBL18503945

SCHEMBL18503945

c1ccc(-c2ccc(-c3nc(-c4cccc(-c5cccc(-c6cccc(-c7cccc(-c8ccccc8)c7)c6)c5)c4)cc4ccccc34)cc2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.44
ALDH1A1 P00352 3/20 0.44
HSD17B10 Q99714 3/20 0.44
HPGD P15428 2/20 0.44
TSHR P16473 1/20 0.44
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
MAPT P10636 2/20 0.42
POLB P06746 1/20 0.42
PKM P14618 1/20 0.42
RAB9A P51151 1/20 0.42
IDO1 P14902 1/20 0.41
TDO2 P48775 1/20 0.41
DHODH Q02127 1/20 0.41
CYP1A1 P04798 1/20 0.40
CYP1B1 Q16678 1/20 0.40
ADORA3 P0DMS8 1/20 0.40
ADORA2A P29274 1/20 0.40
NUDT1 P36639 1/20 0.40
ACHE P22303 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18503996 0.98 KDM4E (0.42) KDM4EALDH1A1HSD17B10HPGDTSHR
SCHEMBL18503942 0.98 KDM4E (0.45) KDM4EALDH1A1HSD17B10HPGDTSHR
SCHEMBL18503994 0.97 KDM4E (0.44) KDM4EALDH1A1HSD17B10HPGDTSHR
SCHEMBL18503948 0.95 IDO1 (0.42) KDM4EALDH1A1HSD17B10HPGDTSHR
SCHEMBL18504050 0.94 KDM4E (0.40) KDM4EALDH1A1HSD17B10HPGDTSHR
SCHEMBL18503946 0.93 IDO1 (0.41) KDM4EALDH1A1HSD17B10HPGDTSHR
SCHEMBL18504002 0.93 IDO1 (0.41) KDM4EALDH1A1HSD17B10HPGDTSHR
SCHEMBL18504005 0.93 IDO1 (0.41) KDM4EALDH1A1HSD17B10HPGDTSHR
SCHEMBL18503964 0.92 MKNK1 (0.49) KDM4EALDH1A1HSD17B10HPGDTSHR
SCHEMBL18504048 0.92 KDM4E (0.41) KDM4EALDH1A1HSD17B10HPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10446764-B2 Organic compound, composition, organic optoelectric device, and display device SAMSUNG SDI CO., LTD. (KR) 2019-10-15 US disclosed
US-20170047529-A1 ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2017-02-16 US disclosed
US-20170047529-A1 ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2017-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10446764-B2 Organic compound, composition, organic optoelectric device, and display device OXER1, OCIAD1, OCIAD2 KDM4E 4289/4885ALDH1A1 129/4885HSD17B10 729/4885
US-20170047529-A1 ORGANIC COMPOUND, COMPOSITION, ORGANIC OPTOELECTRIC DEVICE, AND DISPLAY DEVICE OXER1, OCIAD1, OCIAD2 KDM4E 4289/4885ALDH1A1 129/4885HSD17B10 729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.